Chris Dow
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cytokine Signaling Pathways and Interactions
Papers in
- Co-authors
- Kathryn Field (1 shared paper)Michael Michael (1 shared paper)Louise M. Judd (2 shared papers)Wayne A. Phillips (3 shared papers)Steven Rockman (2 shared papers)Robert J. S. Thomas (2 shared papers)Neville D. Yeomans (2 shared papers)S. Currie (1 shared paper)
- Journals
- ANZ Journal of Surgery (2 papers)Cancer Letters (1 paper)Histopathology (1 paper)The Lancet Oncology (1 paper)Journal of Gastroenterology and Hepatology (1 paper)
- Partner nations
- Australia
In The Last Decade
Chris Dow
10 papers receiving 549 citations
Peers
Comparison fields: 5 of 74
- Hepatology 65
- Oncology 177
- Immunology 120
- Surgery 216
- Cancer Research 52
Countries citing papers authored by Chris Dow
This map shows the geographic impact of Chris Dow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Dow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Dow more than expected).
Fields of papers citing papers by Chris Dow
This network shows the impact of papers produced by Chris Dow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Dow. The network helps show where Chris Dow may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris Dow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 144 | |
| 2 | 2001 | 122 | |
| 3 | 2008 | 102 | |
| 4 | 2007 | 91 | |
| 5 | 2002 | 44 | |
| 6 | 1997 | 20 | |
| 7 | 2000 | 15 | |
| 8 | 2000 | 15 | |
| 9 | 2008 | 4 | |
| 10 | 2003 | 1 | |
| 11 | 2011 | 0 | |
| 12 | 2014 | 0 | |
| 13 | 2021 | 0 |
About Chris Dow
Chris Dow is a scholar working on Oncology, Surgery, Molecular Biology, Genetics and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 558 indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer-related gene regulation (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Genetic and Kidney Cyst Diseases (1 paper) and Genetic factors in colorectal cancer (1 paper). The work is most often cited by research in Hepatology (65 citations), Oncology (177 citations), Immunology (120 citations), Surgery (216 citations) and Cancer Research (52 citations). Chris Dow has collaborated with scholars based in Australia. Frequent co-authors include Kathryn Field, Michael Michael, Louise M. Judd, Wayne A. Phillips, Steven Rockman, Robert J. S. Thomas, Neville D. Yeomans, S. Currie, Elizabeth Vincan and Brendan J. Jenkins. Their work appears in journals such as ANZ Journal of Surgery, Cancer Letters, Histopathology, The Lancet Oncology and Journal of Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.